Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Gross Margin (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Gross Margin for 16 consecutive years, with 71.66% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 240.0% to 71.66% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 71.53% through Dec 2025, up 290.0% year-over-year, with the annual reading at 71.53% for FY2025, 290.0% up from the prior year.
  • Gross Margin for Q4 2025 was 71.66% at Lemaitre Vascular, down from 75.28% in the prior quarter.
  • The five-year high for Gross Margin was 75.28% in Q3 2025, with the low at 63.62% in Q4 2022.
  • Average Gross Margin over 5 years is 67.28%, with a median of 66.18% recorded in 2021.
  • The sharpest move saw Gross Margin tumbled -272bps in 2021, then skyrocketed 746bps in 2025.
  • Over 5 years, Gross Margin stood at 65.71% in 2021, then dropped by -3bps to 63.62% in 2022, then grew by 7bps to 68.05% in 2023, then increased by 2bps to 69.26% in 2024, then rose by 3bps to 71.66% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 71.66%, 75.28%, and 70.02% for Q4 2025, Q3 2025, and Q2 2025 respectively.